← Leaderboards
Bradley L Hodges
Prothelia Inc.
$992,988
Attributed
$992,988
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $529K · FY2009–10$1M$750K$500K$250K$0
'09
'10
Funding mix
By agency
NIH$992,988 · 3
By mechanism
R43$992,988 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsHuman Itga7 ProteinProteinsPublic Health RelevanceFundingMouse ModelLamininMuscular Dystrophy, DuchenneSmall MoleculeSkeletalMuscular DystrophiesMembraneExtracellularCell AdhesionFeedingLinkMuscleIntravenousDefectBaseDoseCongenital Muscular DystrophyExtracellular Matrix ProteinsIntramuscular
Grant awards (4)
Hit to Lead Optimization of Small Molecule Therapeutics for Muscular Dystrophy$503,756
R43 · FY2010 · AR · contact PI
Intravenous Protein Therapy for Treatment of Congenital Muscular Dystrophy$25,195
R43 · FY2010 · AR · contact PI
Intravenous Protein Therapy for the Treatment of Duchenne Muscular Dystrophy$251,936
R43 · FY2009 · AR · contact PI
Intravenous Protein Therapy for Treatment of Congenital Muscular Dystrophy$212,101
R43 · FY2009 · AR · contact PI